BAYRY's fourth-quarter earnings match expectations. Revenues top estimates, driven by the strong performance of its ...

Bayer Aktiengesellschaft ( OTCPK:BAYZF) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ET Jost Reinhard - IR Bill Anderson - Chairman & CEO Wolfgang Nickl - CFO Rodrigo Santos - President, ...

As health lawsuits cut into corporate profits, pesticide giant pushes Cancer Gag Act legislation to cover their losses ...

Bayer reported Q4 adjusted EPS of $0.28, missing estimates, but sales beat forecasts. The company sees 2025 as a tough year, with growth expected from 2026.

Consumer health company Kenvue said on Wednesday it had appointed three new directors to its board as part of an agreement ...

While Bayer’s consumer and crop science divisions continued to slide—both in the fourth quarter and in 2024 overall—the ...

Lori Bayer, a Charleston woman who survived breast cancer, has founded a nonprofit organization called "Swing for the ...

Company and Starboard Value LP Enter into Cooperation Agreement SKILLMAN, N.J.--BUSINESS WIRE--Kenvue Inc. (NYSE: KVUE), the world's largest ...

Kenvue Inc. (NYSE: KVUE), the world’s largest pure-play consumer health company by revenue, today announced the appointment ...

Kenvue settled its proxy fight with activist Starboard Value, adding three new directors to its board.

"It is the second year in Bayer's turnaround and will be the most difficult in terms of financial performance," the German company said Wednesday. Bayer also launched a multiyear plan to improve ...

Bayer guided for lower earnings this year as it continues to work through a turnaround plan, but said performance is expected to improve from 2026.